Tatva Chintan Pharma Chem Ltd posts rise in Q1FY26 consolidated PAT to Rs. 6.65 crores

Tatva Chintan Pharma Chem Ltd has reported Consolidated financial results for the period ended June 30, 2025.

Financial Results (Q1 FY2026) - QoQ Comparison

The company has reported total income of Rs. 118.019 crores during the period ended June 30, 2025 as compared to Rs. 108.586 crores during the period ended March 31, 2025.

The company has posted net profit / (loss) of Rs. 6.651 crores for the period ended June 30, 2025 as against net profit / (loss) of Rs. 1.030 crores for the period ended March 31, 2025.

The company has reported EPS of Rs. 2.84 for the period ended June 30, 2025 as compared to Rs. 0.44 for the period ended March 31, 2025.

Financials	Q1 FY2026	Q4 FY2025	% Change
Total Income	₹118.019 crs	₹108.586 crs	8.69%
Net Profit	₹6.651 crs	₹1.030 crs	545.73%
EPS	₹2.84	₹0.44	545.45%

Financial Results (Q1 FY2026) - YoY Comparison

The company has reported total income of Rs.118.019 crores during the period ended June 30, 2025 as compared to Rs.106.637 crores during the period ended June 30, 2024.

The company has posted net profit / (loss) of Rs.6.651 crores for the period ended June 30, 2025 as against net profit / (loss) of Rs.5.209 crores for the period ended June 30, 2024.

The company has reported EPS of Rs.2.84 for the period ended June 30, 2025 as compared to Rs.2.23 for the period ended June 30, 2024.

Financials	Q1 FY2026	Q1 FY2025	% Change
Total Income	₹118.019 crs	₹106.637 crs	10.67%
Net Profit	₹6.651 crs	₹5.209 crs	27.68%
EPS	₹2.84	₹2.23	27.35%

Shares of Tatva Chintan Pharma Chem Ltd was last trading in BSE at Rs. 1016.60 as compared to the previous close of Rs. 997.90. The total number of shares traded during the day was 9361 in over 907 trades.

The stock hit an intraday high of Rs. 1030.00 and intraday low of 982.05. The net turnover during the day was Rs. 9476950.00.

Source : Equity Bulls

Keywords

TatvaChintanPharmaChem Q1FY26 Q1FY2026 FY2026 ResultUpdate